Brief: Cara Therapeutics Announces Q4 And Full Year 2022 Financial Results

Tvardi Therapeutics

06/03/2023 23:35

March 6 (Reuters) - Cara Therapeutics Inc  CARA.O :
    * CARA THERAPEUTICS ANNOUNCES FOURTH QUARTER AND FULL YEAR
2022
FINANCIAL RESULTS
    * POSITIVE MOMENTUM ACROSS FIRST FOUR EU LAUNCHES; GLOBAL
ROLLOUT
TO ACCELERATE WITH MOST EU COUNTRIES LAUNCHING IN 2023
    * CARA THERAPEUTICS - PHASE 2/3 CLINICAL PROGRAM OF ORAL
DIFELIKEFALIN IN NP INITIATED IN 2023
    * NDD CKD AND AD PROGRAMS TRACKING TO EXPECTATIONS WITH
INTERNAL
READOUT FROM KIND 1 PART A EXPECTED IN 2H23
    * QTRLY LOSS PER SHARE $0.56
    * Q4 EARNINGS PER SHARE VIEW $-0.32, REVENUE VIEW $16.3
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nGNXb32bB5 
Further company coverage:  CARA.O 

 ((Reuters.Briefs@thomsonreuters.com;))